Medications for Nonst Elevated Myocardial Infarction

4 results
  • Wockhardt Limited
    Usage: Clopidogrel is indicated for patients with acute coronary syndrome (ACS) to reduce the risk of cardiovascular death, myocardial infarction (MI), or stroke. It is also used in individuals with recent MI, recent stroke, or established peripheral arterial disease to decrease the incidence of new ischemic events and vascular death.
  • Accord Healthcare Inc.
    Usage: Prasugrel is indicated for reducing thrombotic cardiovascular events in acute coronary syndrome patients undergoing percutaneous coronary intervention. This includes those with unstable angina, non-ST-elevation myocardial infarction, and ST-elevation myocardial infarction, showing efficacy in decreasing cardiovascular death and nonfatal myocardial infarction compared to clopidogrel.
  • Golden State Medical Supply, Inc.
    Usage: Prasugrel tablets are indicated for reducing thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), including those with unstable angina, non-ST-elevation myocardial infarction, and ST-elevation myocardial infarction managed with PCI.
  • American Health Packaging
    Usage: Prasugrel tablets are indicated to reduce thrombotic cardiovascular events, including stent thrombosis, in patients with acute coronary syndrome undergoing percutaneous coronary intervention. This includes patients with unstable angina, non-ST-elevation myocardial infarction, and ST-elevation myocardial infarction.